JPRN-UMIN000051645
Recruiting
未知
Efficacy and safety of lenvatinib for patients with advanced or recurrent thymic carcinoma: A real-world retrospective study - Efficacy and safety of lenvatinib for patients with advanced or recurrent thymic carcinoma: A real-world retrospective study
Graduate School of Medicine, Chiba University0 sites80 target enrollmentJuly 19, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- nresectable advanced or recurrent thymic carcinoma
- Sponsor
- Graduate School of Medicine, Chiba University
- Enrollment
- 80
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who have expressed their refusal to participate in this study through an information disclosure document
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The study of efficacy of lenvatinib in patients with hepatocellular carcinoma(HCC): Multicenter analysis.Hepatocellular carcinomaJPRN-UMIN000037054Yokohama City University Medical Center250
Completed
Not Applicable
The safety and efficacy of Lenvatinib for patients with unresectable hepatocellular carcinoma on practical medicine after the approvalHepatocellular carcinomaJPRN-UMIN000034333ational Hospital Organization Kyoto Medical Center500
Active, not recruiting
Phase 1
Treatment for patients whith graft-versus-host disease after bone marrow transplantation.Chronic graft-versus-host disease .MedDRA version: 14.1Level: LLTClassification code 10008907Term: Chronic GVH diseaseSystem Organ Class: 100000004870Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-000770-36-BECHU-ULg5
Active, not recruiting
Phase 1
A phase II study to evaluate the safety and efficacy of lenvatinib in patients with advanced grade 1/2 neuroendocrine neoplasmas of pancreatic and extrapancreatic origin.EUCTR2015-001467-39-ITGETNE (GRUPO ESPAñOL DE TUMORES NEUROENDOCRINOS)110
Completed
Not Applicable
Safety and efficacy of lenalidomide for patients with relapsed or refractory adult T cell leukemia/lymphoma post allogeneic hematopoietic stem cell transplantation, multi-institutional prospective observational trialAdult T-cell leukemia-lymphomaJPRN-UMIN000029635Kagoshima University33